These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31340777)

  • 1. Statin use and the risk of ovarian and endometrial cancers: a meta-analysis.
    Wang Y; Ren F; Song Z; Chen P; Liu S; Ouyang L
    BMC Cancer; 2019 Jul; 19(1):730. PubMed ID: 31340777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials.
    Liu Y; Qin A; Li T; Qin X; Li S
    Gynecol Oncol; 2014 Jun; 133(3):647-55. PubMed ID: 24736024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between statin use and the risk, prognosis of gynecologic cancer: A meta-analysis.
    Chen Y; Han L; Zheng A
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():74-81. PubMed ID: 34875557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative.
    Desai P; Wallace R; Anderson ML; Howard BV; Ray RM; Wu C; Safford M; Martin LW; Rohan T; Manson JE; Simon MS
    Gynecol Oncol; 2018 Mar; 148(3):540-546. PubMed ID: 29422345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of bisphosphonates on the risk of endometrial and ovarian malignancies.
    Rennert G; Rennert HS; Pinchev M; Lavie O
    Gynecol Oncol; 2014 May; 133(2):309-13. PubMed ID: 24556062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use and female reproductive organ cancer risk in a large population-based setting.
    Yu O; Boudreau DM; Buist DS; Miglioretti DL
    Cancer Causes Control; 2009 Jul; 20(5):609-16. PubMed ID: 19043788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis of studies assessing the relationship between statin use and risk of ovarian cancer.
    Irvin S; Clarke MA; Trabert B; Wentzensen N
    Cancer Causes Control; 2020 Oct; 31(10):869-879. PubMed ID: 32685996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis.
    Myung SK; Ju W; Choi HJ; Kim SC;
    BJOG; 2009 Dec; 116(13):1697-705. PubMed ID: 19775307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk reduction of endometrial and ovarian cancer after bisphosphonates use: A meta-analysis.
    Zhang XS; Zhang YM; Li B; Fan B; Zhao Y; Yang SJ
    Gynecol Oncol; 2018 Sep; 150(3):509-514. PubMed ID: 29960711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of statins on risk and survival of gynecological malignancies.
    Lavie O; Pinchev M; Rennert HS; Segev Y; Rennert G
    Gynecol Oncol; 2013 Sep; 130(3):615-9. PubMed ID: 23718932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do statins play any role in reducing the incidence and mortality of ovarian cancer? A systematic review and meta-analysis.
    Mohammadian-Hafshejani A; Sherwin CMT; Heidari-Soureshjani S
    J Prev Med Hyg; 2020 Sep; 61(3):E331-E339. PubMed ID: 33150223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin use and risk of endometrial cancer: a nationwide registry-based case-control study.
    Sperling CD; Verdoodt F; Friis S; Dehlendorff C; Kjaer SK
    Acta Obstet Gynecol Scand; 2017 Feb; 96(2):144-149. PubMed ID: 27891577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of statins, aspirin, and venous thromboembolism in women with endometrial cancer.
    Matsuo K; Hom MS; Yabuno A; Shida M; Kakuda M; Adachi S; Mandelbaum RS; Ueda Y; Hasegawa K; Enomoto T; Mikami M; Roman LD
    Gynecol Oncol; 2019 Mar; 152(3):605-611. PubMed ID: 30616901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between statin use and endometrial cancer survival outcome: A meta-analysis.
    Li J; Liu R; Sun Z; Tang S; Wang L; Liu C; Zhao W; Yao Y; Sun C
    Medicine (Baltimore); 2018 Nov; 97(47):e13264. PubMed ID: 30461633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use and risk of Parkinson's disease: A meta-analysis.
    Sheng Z; Jia X; Kang M
    Behav Brain Res; 2016 Aug; 309():29-34. PubMed ID: 27131781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study.
    Laaksonen MA; Arriaga ME; Canfell K; MacInnis RJ; Byles JE; Banks E; Shaw JE; Mitchell P; Giles GG; Magliano DJ; Gill TK; Klaes E; Velentzis LS; Hirani V; Cumming RG; Vajdic CM
    Gynecol Oncol; 2019 Jun; 153(3):580-588. PubMed ID: 30935715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary acrylamide intake and risk of women's cancers: a systematic review and meta-analysis of prospective cohort studies.
    Benisi-Kohansal S; Salari-Moghaddam A; Seyed Rohani Z; Esmaillzadeh A
    Br J Nutr; 2021 Nov; 126(9):1355-1363. PubMed ID: 33413725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use is associated with improved survival in ovarian cancer: A retrospective population-based study.
    Couttenier A; Lacroix O; Vaes E; Cardwell CR; De Schutter H; Robert A
    PLoS One; 2017; 12(12):e0189233. PubMed ID: 29261726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use and risk of breast cancer: a meta-analysis of observational studies.
    Undela K; Srikanth V; Bansal D
    Breast Cancer Res Treat; 2012 Aug; 135(1):261-9. PubMed ID: 22806241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis.
    Siristatidis C; Sergentanis TN; Kanavidis P; Trivella M; Sotiraki M; Mavromatis I; Psaltopoulou T; Skalkidou A; Petridou ET
    Hum Reprod Update; 2013; 19(2):105-23. PubMed ID: 23255514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.